Logo image of ABLD.PA

ABL DIAGNOSTICS (ABLD.PA) Stock Fundamental Analysis

EPA:ABLD - Euronext Paris - Matif - FR001400AHX6 - Common Stock - Currency: EUR

8.1  0 (0%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to ABLD. ABLD was compared to 16 industry peers in the Trading Companies & Distributors industry. The financial health of ABLD is average, but there are quite some concerns on its profitability. While showing a medium growth rate, ABLD is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year ABLD was profitable.
ABLD had a positive operating cash flow in the past year.
In multiple years ABLD reported negative net income over the last 5 years.
In the past 5 years ABLD reported 4 times negative operating cash flow.
ABLD.PA Yearly Net Income VS EBIT VS OCF VS FCFABLD.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 1M -1M

1.2 Ratios

ABLD's Return On Assets of 1.36% is in line compared to the rest of the industry. ABLD outperforms 43.75% of its industry peers.
The Return On Equity of ABLD (2.70%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA 1.36%
ROE 2.7%
ROIC N/A
ROA(3y)5.68%
ROA(5y)2.48%
ROE(3y)9.01%
ROE(5y)4.47%
ROIC(3y)N/A
ROIC(5y)N/A
ABLD.PA Yearly ROA, ROE, ROICABLD.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 0 10 20

1.3 Margins

ABLD has a Profit Margin (3.13%) which is in line with its industry peers.
ABLD's Profit Margin has declined in the last couple of years.
The Operating Margin and Gross Margin are not available for ABLD so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 3.13%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5Y-71%
GM growth 3YN/A
GM growth 5YN/A
ABLD.PA Yearly Profit, Operating, Gross MarginsABLD.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 100 200 300 400

More info and screens

5

2. Health

2.1 Basic Checks

ABLD does not have a ROIC to compare to the WACC, probably because it is not profitable.
ABLD has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for ABLD has been increased compared to 5 years ago.
The debt/assets ratio for ABLD is higher compared to a year ago.
ABLD.PA Yearly Shares OutstandingABLD.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M
ABLD.PA Yearly Total Debt VS Total AssetsABLD.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M

2.2 Solvency

ABLD has an Altman-Z score of 12.59. This indicates that ABLD is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of ABLD (12.59) is better than 100.00% of its industry peers.
ABLD has a Debt/Equity ratio of 0.26. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of ABLD (0.26) is better than 75.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF N/A
Altman-Z 12.59
ROIC/WACCN/A
WACC7.86%
ABLD.PA Yearly LT Debt VS Equity VS FCFABLD.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 2M 4M 6M

2.3 Liquidity

A Current Ratio of 2.06 indicates that ABLD has no problem at all paying its short term obligations.
The Current ratio of ABLD (2.06) is better than 62.50% of its industry peers.
ABLD has a Quick Ratio of 1.92. This is a normal value and indicates that ABLD is financially healthy and should not expect problems in meeting its short term obligations.
ABLD has a Quick ratio of 1.92. This is amongst the best in the industry. ABLD outperforms 87.50% of its industry peers.
Industry RankSector Rank
Current Ratio 2.06
Quick Ratio 1.92
ABLD.PA Yearly Current Assets VS Current LiabilitesABLD.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M

More info and screens

6

3. Growth

3.1 Past

ABLD shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -70.74%.
Measured over the past years, ABLD shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -66.52% on average per year.
The Revenue for ABLD has decreased by -47.26% in the past year. This is quite bad
Measured over the past years, ABLD shows a very strong growth in Revenue. The Revenue has been growing by 74.86% on average per year.
EPS 1Y (TTM)-70.74%
EPS 3YN/A
EPS 5Y-66.52%
EPS Q2Q%675%
Revenue 1Y (TTM)-47.26%
Revenue growth 3YN/A
Revenue growth 5Y74.86%
Sales Q2Q%11.83%

3.2 Future

The Earnings Per Share is expected to grow by 162.07% on average over the next years. This is a very strong growth
ABLD is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 32.29% yearly.
EPS Next Y800%
EPS Next 2Y324.26%
EPS Next 3Y162.07%
EPS Next 5YN/A
Revenue Next Year15.22%
Revenue Next 2Y24.43%
Revenue Next 3Y32.29%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
ABLD.PA Yearly Revenue VS EstimatesABLD.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2M 4M 6M 8M 10M
ABLD.PA Yearly EPS VS EstimatesABLD.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.02 0.04 0.06

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 810.00, ABLD can be considered very expensive at the moment.
62.50% of the companies in the same industry are cheaper than ABLD, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of ABLD to the average of the S&P500 Index (29.35), we can say ABLD is valued expensively.
ABLD is valuated quite expensively with a Price/Forward Earnings ratio of 132.35.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ABLD indicates a slightly more expensive valuation: ABLD is more expensive than 62.50% of the companies listed in the same industry.
ABLD is valuated expensively when we compare the Price/Forward Earnings ratio to 22.10, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 810
Fwd PE 132.35
ABLD.PA Price Earnings VS Forward Price EarningsABLD.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 200 400 600 800

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ABLD.PA Per share dataABLD.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 0.2 0.3 0.4

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
ABLD's earnings are expected to grow with 162.07% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.01
PEG (5Y)N/A
EPS Next 2Y324.26%
EPS Next 3Y162.07%

More info and screens

0

5. Dividend

5.1 Amount

ABLD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ABL DIAGNOSTICS

EPA:ABLD (3/7/2025, 7:00:00 PM)

8.1

0 (0%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryTrading Companies & Distributors
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners99.64%
Ins Owner ChangeN/A
Market Cap130.49M
Analysts85.71
Price Target6.28 (-22.47%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 810
Fwd PE 132.35
P/S 22.11
P/FCF N/A
P/OCF 164.22
P/B 19.05
P/tB 31.06
EV/EBITDA N/A
EPS(TTM)0.01
EY0.12%
EPS(NY)0.06
Fwd EY0.76%
FCF(TTM)0
FCFYN/A
OCF(TTM)0.05
OCFY0.61%
SpS0.37
BVpS0.43
TBVpS0.26
PEG (NY)1.01
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.36%
ROE 2.7%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 3.13%
GM N/A
FCFM N/A
ROA(3y)5.68%
ROA(5y)2.48%
ROE(3y)9.01%
ROE(5y)4.47%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5Y-71%
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.43
Health
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 13.8%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.06
Quick Ratio 1.92
Altman-Z 12.59
F-Score4
WACC7.86%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-70.74%
EPS 3YN/A
EPS 5Y-66.52%
EPS Q2Q%675%
EPS Next Y800%
EPS Next 2Y324.26%
EPS Next 3Y162.07%
EPS Next 5YN/A
Revenue 1Y (TTM)-47.26%
Revenue growth 3YN/A
Revenue growth 5Y74.86%
Sales Q2Q%11.83%
Revenue Next Year15.22%
Revenue Next 2Y24.43%
Revenue Next 3Y32.29%
Revenue Next 5YN/A
EBIT growth 1Y-76.32%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year254.01%
EBIT Next 3Y82.12%
EBIT Next 5YN/A
FCF growth 1Y89.17%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y541.44%
OCF growth 3YN/A
OCF growth 5Y62.76%